Related references
Note: Only part of the references are listed.Alternative conformations of a major antigenic site on RSV F
Harrison G. Jones et al.
PLOS PATHOGENS (2019)
Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
Ralph A. Tripp et al.
JOURNAL OF VIROLOGY (2018)
Structural Basis for Escape of Human Astrovirus from Antibody Neutralization: Broad Implications for Rational Vaccine Design
Walter A. Bogdanoff et al.
JOURNAL OF VIROLOGY (2018)
Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
Caroline Amand et al.
BMC HEALTH SERVICES RESEARCH (2018)
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
Natalie I. Mazur et al.
LANCET INFECTIOUS DISEASES (2018)
Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
Harrison G. Jones et al.
PLOS PATHOGENS (2018)
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains
Jeehyun Lee et al.
PLOS PATHOGENS (2018)
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4
Guillaume B. E. Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies
Stanislav O. Fedechkin et al.
SCIENCE IMMUNOLOGY (2018)
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
Cristina Capella et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells
B. Cortjens et al.
JOURNAL OF VIROLOGY (2017)
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective
S. Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2017)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
Michael B. Battles et al.
NATURE COMMUNICATIONS (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
Lori M. Cullen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
Hyo-Jeong Lee et al.
PLOS ONE (2017)
Antibody Recognition of Disordered Antigens
Christopher A. MacRaild et al.
STRUCTURE (2016)
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells
Tatiana Chirkova et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels
Sandra Fuentes et al.
JOURNAL OF VIROLOGY (2015)
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Antonietta Impagliazzo et al.
SCIENCE (2015)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice
Seyhan Boyoglu-Barnum et al.
VIROLOGY (2015)
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
Anders Krarup et al.
NATURE COMMUNICATIONS (2015)
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
Sara M. Johnson et al.
PLOS PATHOGENS (2015)
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner
Kwang-Il Jeong et al.
PLOS ONE (2015)
Effects of Anti-G and Anti-F Antibodies on Airway Function after Respiratory Syncytial Virus Infection
Junyan Han et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2014)
Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences
Masanori Yagi et al.
PLOS ONE (2014)
Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines
Yuan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization
Lu Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Two potential therapeutic antibodies bind to a peptide segment of membrane-bound IgE in different conformations
Hsing-Mao Chu et al.
NATURE COMMUNICATIONS (2014)
How good are my data and what is the resolution?
Philip R. Evans et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses
Tatiana Chirkova et al.
JOURNAL OF VIROLOGY (2013)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
RSV Immunoprophylaxis: Does the Benefit Justify the Cost?
H. Cody Meissner et al.
PEDIATRICS (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice
Florian Krammer et al.
JOURNAL OF VIROLOGY (2012)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
Hayat Caidi et al.
PLOS ONE (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice
Gertrud U. Radu et al.
JOURNAL OF VIROLOGY (2010)
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)2 components mediates reduced pulmonary inflammation in mice
Congrong Mao et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
Ellen J. Collarini et al.
JOURNAL OF IMMUNOLOGY (2009)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction
Masashi Shingai et al.
INTERNATIONAL IMMUNOLOGY (2008)
The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses
J Harcourt et al.
JOURNAL OF IMMUNOLOGY (2006)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium
LQ Zhang et al.
JOURNAL OF VIROLOGY (2005)
The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans
E Escribano-Romero et al.
JOURNAL OF VIROLOGY (2004)
Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells
R Arnold et al.
VIROLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P
LM Haynes et al.
JOURNAL OF VIROLOGY (2003)
Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G
M Sugawara et al.
JOURNAL OF PEPTIDE RESEARCH (2002)
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo
MN Teng et al.
VIROLOGY (2001)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene
S Techaarpornkul et al.
JOURNAL OF VIROLOGY (2001)
Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection
LK Hallak et al.
VIROLOGY (2000)
Share Paper
